Effect of pentoxifylline in rat and swine models of hepatic fibrosis: Role of fibroproliferation in its mechanism

Immunopharmacology

Volumn 31, Issue 2-3, 1996, Pages 183-193

  Peterson, Theresa C ^a,b   Neumeister, Michael ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PENTOXIFYLLINE; PHOSPHORUS;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; LIVER FIBROSIS; LIVER FUNCTION; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SWINE;

EID: 0030007465     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(95)00048-8     Document Type: Article

References (35)

1. Peterson, T.C. and Isbrucker, R.A. Fibroproliferation in liver disease: role of monocyte factors. Hepatology 1992; 15, 191-197.
2. Friedman, S.L. The cellular basis of hepatic fibrosis; mechanisms and treatment strategies. N Engl J Med 1993: 328; 1828-1835.
3. Peterson, T.C., Williams, C.N. and Malatjalian, D.A. Monocyte aryl hydrocarbon hydroxylase (AHH) activity mimics Kupffer cell and hepatocyte AHH activity in an animal model of liver disease. Can J Physiol Pharmacol. 1991; 69: 1707-1803.
4. Peterson, T.C., Malatjalian, D. and Williams, C.N. Monocyte AHH activity in a pig model of cirrhosis: does the monocyte enzyme reflect liver enzyme changes. Clin Invest Med 1987; 10, B131.
5. Fletcher, G.F., Galambos, J.T., Phosphorus poisoning in humans. Arch Intern Med 1963; 112: 846-852.
6. Mallory, F.B., Phosphorus and alcoholic cirrhosis. Amer J Path 1933; 9: 557-567.
7. Marin, G.A., Montoya, C.A., Sierra, J.L., Senior, J.R. Evaluation of corticosteroid and exchange transfusion treatment of acute yellow phosphorus intoxication. New Engl J Med 1971; 284: 125-128.
8. Kaplow, L.S., Cytochemical identification of mononuclear macrophages. In: Herscowitz, H.B., et, al., eds. Manual of macrophage methodology. Immunol. Series. New York, Marcel Dekker, Inc. 1981, 13: 199-207.
9. Dohlman, J.G., Payan, D.G. and Goetzl, E.J. Generation of a unique fibroblast activating factor by human monocytes. Immunol 1984; 52: 577-584.
10. Gascon-Barre, M., Huet, P-M., Belgiorno, J., Plourde, V., and Coulombe, P.A., Estimation of collagen content in liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats. J. Histochem Cytochem 1989; 37: 377-381.
11. Lopez-de Leon, A. and Rojkind, M. A simple micromethod for collagen and total protein determination in formalin fixed paraffin embedded sections. J Histochem Cytochem 1985, 33: 737-743.
12. Zar, J.H., Biostatistical methods, Prentice-Hall, Englewood Cliffs, NJ, 1974.
13. Peterson, T.C. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet derived growth factor driven proliferation of fibroblasts. Hepatology 1993, 17: 3; 486-493.
14. Elias, H., Scherrick, J.C. Morphology of the Liver. pp. 125-136, Academic Press, New York, 1969.
15. Dupont, J. et.al., Synthesis and disappearance of cholesterol and bile acids in miniature swine. in; Swine in Biomedical Research vol. 2, (ed. M.E. Tumbleson), Plenum press, New York, pp 821-838, 1986.
16. Freudenthal, R., et.al., Characterization of the hepatic microsomal mixed function oxidase enzyme system in miniature pigs. Drug Metab Dispos 1975; 4: 25-25.
17. Fujimori, K. Takahashi, A., Numata, H., Takanaka, A. Drug metabolising enzyme system of Gottingen miniature pig. in; Swine in Biomedical Research vol. 1, (ed. M.E. Tumbleson), Plenum press, New York, pp 533-548, 1986.
18. Peggins, J.O., Shipley, L.A., Weiner, M. Effects of age on hepatic drug metabolism in miniature swine. In: Swine in Biomedical Research vol. 1, (ed. M.E. Tumbleson), Plenum press, New York, pp 39-44, 1986.
19. Hebda, P.A., Kao, W., Mertz, P.M., Eaglstein, W.H. Collagen biosynthesis and collagen content as a measure of dermal healing in experimental wounds in domestic swine. in; Swine in Biomedical Research vol. 1, (ed. M.E. Tumbleson), Plenum press, New York, pp 303-312, 1986.
20. Accatino, L., Contreras, A., Fenandez, S., Quintana, C. The effect of complete biliary obstruction on bile flow and bile acid secretion; post cholestatic choleresis in the rat. J Lab Clin Med. 1979; 93: 706-717.
21. Gross, JB., Reichen, J., Zeltner, T., Zimmerman, A. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation of morphometric measurement of hepatocyte mass. Hepatology 1987; 7: 457-463.
22. Friedman, S.L., F.J. Roll, S. Boyles, D.M. Bissel. Hepatic lipocytes: the principal collagen producing cells of normal rat liver. Proc Natl Acad Sci USA 1988: 82; 8681-8685.
23. Peterson, T.C. and Isbrucker, R.A. Role of interleukin-1β and PDGF in the AHH depressive and fibrogenic activity of MCM from patients with liver disease. J Leuk Biol 1990; Supp. 1, 52.
24. Peterson, T.C, Isbrucker, R., Hooper, M. In vitro effect of platelet derived growth factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology 1994; 28: 259-270.
25. Kuratsu, J. and Ushio, Y. Antiproliferative effect of trapidil, a platelet derived growth factor antagonist, on a glioma cell line in vitro. J Neurosurg 1990; 73: 436-40.
26. Slysz, G. and Peterson, T.C. Pentoxifylline and trapidil do not inhibit PDGF binding to PDGF receptors of human and rat fibroblasts. Leuk Biol 1994; LB68.
27. Fredholm, B.B. and Lindstrom, K. The xanthine derivative 1-(5'oxohexyl)-3-methyl-7-propylxanthine (HWA285) enhances the action of adenosine. Acta Pharmcol Toxicol 1986; 58: 187.
28. Peterson, T.C. and White, B. Role of adenosine receptors in the inhibition of ftbroproliferation due to pentoxifylline and MI metabolite. Hepatology 1995; 22, 4, A1473.
29. Rice, G.C., Brown, P.A., Nelson, R.J., Bianco, J.A., Singer, J.W. and Bursten, S. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci USA 1994: 91; 3857-3861.
30. Rice, G.C., Brown, P.A., Kazlauskas, A., Singer, J.W., Bianco, J.A. and S. Bursten. Generation of the lipid second messenger molecule, phosphatidic acid (PA) is involved in signal transduction for PDGF, VEGF and FGF-induced mitogenesis. J Cell Biochem 1994; S 18A. 272.
31. Isbrucker, R. and Peterson, T.C. Collagens α(I) and a(III) mRNA levels are increased in a porcine model of hepatic fibrosis and reduced by pentoxifylline administration. Gastroenterology 1994: 106; A1086.
32. Lohmann, S. and Meich, R. Theophylline metabolism in the rat liver microsomal system. J . Pharmacol Exp Ther.1976; 196: 312-225.
33. George, J., Murray, M., Byth, K., Farrell, G., Differential alterations of cytochrome P-450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995; 21, 1, 120-128.
34. Thompson, J., Bianco, J.A., Benyunes, M.C., Neubauer, M.A., Slattery, J. T., Fefer, A. Phase 1-B trial of pentoxifylline and cyprofloxacin in patients treated with interleukin 2 and lymphokine activated killer cell therapy for metastatic renal cell carcinoma. Cancer Res. 1994; 54, 3436-3441.
35. Isbrucker, R.A. and T.C. Peterson. Effect of PDGF, pentoxifylline and metabolite 1 on collagen production in porcine hepatic stellate cells. Hepatology 1995: 22, 4, A696.